MiMedx Group Inc.

MDXG | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.92

+$0.11 (+2.29%)

Sep 22, 2026, 2:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $701.11M

Enterprise Value $566.77M

Beta 1.42

Average Volume 1.4M

Shares Outstanding (Diluted) 147.8M

Shares Change YoY -1.02%

Institutional Ownership 76.06%

Exchange NASDAQ

ISIN US6024961012

Price Performance

Price Change 1M 10.6%

Price Change 3M 28.9%

Price Change 6M 17.3%

Price Change YTD -25.8%

Price Change 1Y -33.1%

Price Change 3Y -36.5%

Price Change 5Y -23.0%

1M CAGR (ann.) 10.8%

1Y CAGR (ann.) -32.7%

5Y CAGR (ann.) -5.2%

All-Time CAGR 0.2%

Valuation

PE Ratio 120.25

Forward PE 21.54

PEG Ratio -1.47

Forward PEG -0.41

PS Ratio 1.97

Forward PS 2.10

PB Ratio 3.25

P/FCF Ratio 16.71

P/Adj. FCF Ratio 19.83

P/OCF Ratio 15.52

EV/Sales 1.60

EV/EBIT 44.55

EV/EBITDA 23.92

EV/FCF 13.51

Earnings Yield 0.8%

FCF Yield 6.0%

Adj. FCF Yield 5.0%

Financial Health

Net Cash $134.34M

Total Debt $1.5M

Cash & Short-Term Investments $135.84M

Total Assets $281M

Current Ratio 5.33

Quick Ratio 4.79

Debt / Equity Ratio 0.01

Debt / EBITDA 0.06

Debt / FCF 0.04

OCF / Debt 30.77

Interest Coverage 5.50

Altman Z-Score 8.26

Piotroski F-Score 6

Margins & Profitability

Gross Profit Margin 78.8%

Operating Profit Margin 2.5%

EBITDA Margin 6.7%

Net Profit Margin 1.8%

FCF Margin 11.8%

Adj. FCF Margin 9.9%

SBC / Revenue 1.9%

SBC Impact (per share) -15.7%

Returns

Return on Assets 2.2%

Return on Equity 2.6%

Return on Invested Capital 1.9%

Return on Capital Employed 3.6%

Return on Tangible Assets 2.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 6.4%

Revenue CAGR 5Y 6.4%

Revenue CAGR 10Y 5.3%

EPS CAGR 3Y -97.1%

EPS CAGR 5Y 79.8%

EPS CAGR 10Y -15.3%

FCF CAGR 3Y -1.4%

FCF CAGR 5Y 67.0%

FCF CAGR 10Y 15.3%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 15

EPS Growth Next 3Y 71.0%

Revenue Growth Next 3Y 2.0%

Earnings Date Nov 3, 2026

EPS Estimate (next Q) $0.01

EPS Growth Est (next Q) -95.5%

Revenue Est (next Q) $69.65M

Revenue Growth Est (next Q) -38.8%

Fair Value Estimates

Graham Number $1.15

Graham Upside -76.1%

Lynch Fair Value $1

Lynch Upside -79.2%

Price Target $7.67

Price Target Upside 59.5%

Cash Flow

Operating Cash Flow $46.15M

Free Cash Flow $41.95M

Adj. Free Cash Flow $35.36M

FCF Per Share $0.27

OCF Per Share $0.31

OCF/S Ratio 13.0%

Income Statement

Revenue $355.17M

Gross Profit $280.05M

Operating Income $8.75M

EBITDA $23.69M

Net Income $6.24M

EPS (Diluted) $0.04

Revenue / Employee $439.57K

Profit / Employee $7.72K

Employees 808